EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents

Yanni Hao, Nicole Meyer, William Johnson, Jaqueline Willemann Rogerio, Pamela Landsman-Blumberg

Comparative Effectiveness Research · 2015

DOI: 10.2147/cer.s73220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comparative Effectiveness Research, 2015. Verfasst von Yanni Hao und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hao, Y., Meyer, N., Johnson, W., Rogerio, J. W., & Landsman-Blumberg, P. (2015). Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents. Comparative Effectiveness Research. https://doi.org/10.2147/cer.s73220

Vancouver

Hao Y, Meyer N, Johnson W, Rogerio JW, Landsman-Blumberg P. Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents. Comparative Effectiveness Research. 2015. doi:10.2147/cer.s73220

BibTeX
@article{Hao2015,
  author = {Hao, Yanni and Meyer, Nicole and Johnson, William and Rogerio, Jaqueline Willemann and Landsman-Blumberg, Pamela},
  title = {Treatment characteristics and mortality of a large insured female population with advanced or metastatic breast cancer by receipt of HER2-targeted agents},
  journal = {Comparative Effectiveness Research},
  year = {2015},
  doi = {10.2147/cer.s73220}
}
Kostenlos starten →